ASRT Assertio Holdings Inc. Forecast, Technical & Fundamental Analysis
Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs... Show more
ASRT is expected to report earnings to fall 87.80% to -35 cents per share on July 30
Q2'26
Est.
$-0.36
Q1'26
Missed
by $2.88
Q4'25
Missed
by $0.99
Q3'25
Beat
by $0.27
Q2'25
Beat
by $0.10
The last earnings report on May 08 showed earnings per share of -293 cents, missing the estimate of -5 cents. With 486.53K shares outstanding, the current market capitalization sits at 151.73M.
A.I.dvisor tells us that ASRT and SNOA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and SNOA's prices will move in lockstep.
ASRT in -0.08% downward trend, sliding for three consecutive days on June 08, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ASRT declined for three days, in of 296 cases, the price declined further within the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for ASRT turned negative on May 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 09, 2026. You may want to consider a long position or call options on ASRT as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ASRT advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 226 cases where ASRT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ASRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.006) is normal, around the industry mean (144.130). P/E Ratio (0.000) is within average values for comparable stocks, (97.681). Projected Growth (PEG Ratio) (0.895) is also within normal values, averaging (1.601). ASRT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (1.475) is also within normal values, averaging (95.029).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
